PT2900251T - Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica - Google Patents

Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica

Info

Publication number
PT2900251T
PT2900251T PT137740866T PT13774086T PT2900251T PT 2900251 T PT2900251 T PT 2900251T PT 137740866 T PT137740866 T PT 137740866T PT 13774086 T PT13774086 T PT 13774086T PT 2900251 T PT2900251 T PT 2900251T
Authority
PT
Portugal
Prior art keywords
treatment
metabolic syndrome
olea europaea
cynara scolymus
coffea spp
Prior art date
Application number
PT137740866T
Other languages
English (en)
Inventor
Bombardelli Ezio
Corti Fabrizio
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PT2900251T publication Critical patent/PT2900251T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/742—Coffea, e.g. coffee
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT137740866T 2012-09-20 2013-09-19 Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica PT2900251T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001570A ITMI20121570A1 (it) 2012-09-20 2012-09-20 Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica

Publications (1)

Publication Number Publication Date
PT2900251T true PT2900251T (pt) 2017-01-18

Family

ID=47146491

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137740866T PT2900251T (pt) 2012-09-20 2013-09-19 Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica

Country Status (20)

Country Link
US (1) US9248157B2 (pt)
EP (1) EP2900251B1 (pt)
JP (1) JP6265388B2 (pt)
KR (1) KR102211814B1 (pt)
CN (1) CN104640555A (pt)
AU (1) AU2013320237B2 (pt)
BR (1) BR112015005942B1 (pt)
CA (1) CA2886887C (pt)
DK (1) DK2900251T3 (pt)
ES (1) ES2613381T3 (pt)
HK (1) HK1210597A1 (pt)
HU (1) HUE031901T2 (pt)
IL (1) IL237803B (pt)
IT (1) ITMI20121570A1 (pt)
PL (1) PL2900251T3 (pt)
PT (1) PT2900251T (pt)
RU (1) RU2657757C2 (pt)
SG (1) SG11201502096VA (pt)
SI (1) SI2900251T1 (pt)
WO (1) WO2014044744A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015158895A1 (en) * 2014-04-17 2015-10-22 Indena S.P.A. Coffee extracts and formulations containing them
CN105078823A (zh) * 2015-08-14 2015-11-25 广东艾圣日用化学品有限公司 一种减肥组合物及其制备方法
FR3042413B1 (fr) * 2015-10-20 2019-07-12 Valbiotis Composition comprenant un melange de molecules extraites de chrysanthellum indicum et de cynara scolymus et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
JP6926453B2 (ja) * 2015-12-03 2021-08-25 大正製薬株式会社 カプセル組成物
JP6907515B2 (ja) * 2015-12-03 2021-07-21 大正製薬株式会社 固形組成物
IT201700040866A1 (it) * 2017-04-12 2018-10-12 Herbal E Antioxidant Derivatives Srl Ed In Forma Abbreviata H&Ad Srl Estratti di cynara scolymus e citrus aurantium bergamia, loro combinazioni e formulazioni che li contengono
CN108727471B (zh) * 2018-06-06 2021-08-27 南京医科大学 一种脂肪组织靶向性多肽-毛蕊花苷-纳米金颗粒衍生物及其制备方法和应用
IT201800007746A1 (it) * 2018-08-01 2020-02-01 Pharmanutrition R&D Srl Composizione orale nutraceutica per uso nel trattamento della sindrome metabolica

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel
US6358542B2 (en) 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
CN102309573B (zh) * 2003-09-12 2013-11-20 捷通国际有限公司 细胞因子调节剂及相关用法
ITMI20051347A1 (it) 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
KR20080041703A (ko) * 2005-08-23 2008-05-13 액세스 비지니스 그룹 인터내셔날 엘엘씨 사이토킨 조절인자 및 관련된 이용 방법
ES2323815T3 (es) * 2007-03-07 2009-07-24 Indena S.P.A. Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
EP1967199A1 (en) 2007-03-07 2008-09-10 Indena S.P.A. Cynara scolymus extracts and compositions containing them
EP1982603A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Novel use of hydroxytyrosol and olive extracts/concentrates containing it
CN101057678B (zh) * 2007-06-13 2010-09-01 深圳市金沙江投资有限公司 一种含有天然植物提取物或单体的组合物
KR101762388B1 (ko) * 2009-01-20 2017-07-28 인데나 에스.피.에이 식도 역류 및 과민성 장 증후군의 예방 및 치료에 유용한, 생강의 친유성 추출물 및 시나라 스콜리무스의 추출물을 포함하는 조성물
IT1397386B1 (it) * 2010-01-12 2013-01-10 Indena Spa Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
JP2012062275A (ja) * 2010-09-16 2012-03-29 Kao Corp 脂質燃焼促進剤
ITMI20111670A1 (it) * 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie

Also Published As

Publication number Publication date
AU2013320237B2 (en) 2017-08-17
DK2900251T3 (en) 2017-02-20
AU2013320237A1 (en) 2015-04-09
CA2886887C (en) 2021-02-23
EP2900251A1 (en) 2015-08-05
US9248157B2 (en) 2016-02-02
HK1210597A1 (en) 2016-04-29
PL2900251T3 (pl) 2017-05-31
SG11201502096VA (en) 2015-04-29
BR112015005942B1 (pt) 2021-05-04
BR112015005942A2 (pt) 2017-07-04
KR20150058234A (ko) 2015-05-28
SI2900251T1 (sl) 2017-03-31
EP2900251B1 (en) 2016-11-16
WO2014044744A1 (en) 2014-03-27
JP6265388B2 (ja) 2018-01-24
RU2015109566A (ru) 2016-10-20
CA2886887A1 (en) 2014-03-27
ITMI20121570A1 (it) 2014-03-21
JP2015532917A (ja) 2015-11-16
HUE031901T2 (en) 2017-08-28
RU2657757C2 (ru) 2018-06-15
IL237803B (en) 2018-03-29
ES2613381T3 (es) 2017-05-24
US20150231193A1 (en) 2015-08-20
CN104640555A (zh) 2015-05-20
KR102211814B1 (ko) 2021-02-04

Similar Documents

Publication Publication Date Title
PT4000608T (pt) Composição farmacêutica, métodos para o tratamento e suas utilizações
BR112014023937A2 (pt) composição farmacêutica, agente farmacêutico de combinação e método de tratamento
CL2014003136A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos.
BR112015003144A2 (pt) dispositivos e sistemas para tratamento de trombos.
BR112015000749A2 (pt) cápsula de fragrância de hidrogel, formulações e processo para preparação das mesmas
PT2755473T (pt) Composições parasiticidas compreendendo um agente ativo de isoxazolina, métodos e suas utilizações
BR112015000527A2 (pt) agente reológico, métodos de preparação e usos dos mesmos.
FR3003566B1 (fr) Composition comprenant hf et e-3,3,3-trifluoro-1-chloropropene
BR112013033072A2 (pt) agente para indução de apoptose e composição farmacêutica
CL2014003232A1 (es) Formulaciones y métodos para la administración vaginal de antiprogestinas.
SG11201502096VA (en) NOVEL EXTRACTS OF CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF METABOLIC SYNDROME
BR112014030159A2 (pt) agente para tratamento de floculação.
IL245908B (en) Consequences of pyranochromanil phenol and a pharmaceutical preparation for the treatment of metabolic syndrome or inflammatory disease
FR3013218B1 (fr) Composition comprenant des capsules gelifiees stabilisees par un tampon
ES2899185T8 (es) Cepas probióticas que tienen capacidad de absorción de colesterol, procedimientos y usos de las mismas
BR112014031512A2 (pt) composição cosmética e método para o tratamento cosmético.
BR112016026552A2 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
PT2968428T (pt) Composição à base de flavonoides para utilização farmacêutica, nutricional ou cosmética tendo ação antioxidante potenciada
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
BR112015010271A2 (pt) produto de comicronização, composição farmacêutica e seus usos
BR112016027383A2 (pt) Derivados de naftiridinadiona, seus usos, composição farmacêutica e combinação
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
PT3054926T (pt) Formulação de atazanavir e cobicistat para tratamento de hiv
BR112014032290A2 (pt) composições e métodos para tratar ou prevenir infecção de pneumovírus e doenças associadas.